AYALA PHARMACEUTICALS INC (AYLA)
US05465V1089 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.47M | -40.25M | -30.15M | -17.79M | -8.87M | |||
| Depreciation Amortization | 149.00K | 168.00K | 180.00K | 150.00K | 50.00K | |||
| Change In Working Capital | 1.56M | -954.00K | 850.00K | 1.97M | 1.84M | |||
| Taxes Paid | 263.00K | 209.00K | 300.00K | 170.00K | 30.00K | |||
| Other non cash items | 2.63M | 2.68M | 1.57M | 730.00K | 610.00K | |||
| OPERATING CASH FLOW | -34.13M | -38.36M | -27.54M | -14.95M | -6.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -5.00K | -50.00K | -1.33M | -220.00K | |||
| Other Investing Activity | N/A | 0.00 | 230.00K | -250.00K | -30.00K | |||
| INVESTING CASH FLOW | 0.00 | -5.00K | 180.00K | -1.58M | -250.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 4.46M | 33.33M | 52.92M | 7.08M | 25.42M | |||
| FINANCING CASH FLOW | 4.46M | 33.33M | 52.92M | 7.08M | 25.42M | |||
| CHANGE IN CASH | -29.68M | -5.03M | 25.56M | -9.45M | 18.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -34.13M | -38.36M | -27.54M | -14.95M | -6.37M | |||
| Capital Expenditure | N/A | -5.00K | -50.00K | -1.33M | -220.00K | |||
| FREE CASH FLOW | -34.13M | -38.36M | -27.59M | -16.28M | -6.59M | |||
All data in USD